Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01943474 · ClinicalTrials.gov registry record · NA
AccuCath Guidewire Intravenous (IV) Device Versus Conventional IV Catheter In General Nursing Use
A NA study, sponsored by C. R. Bard.
- Completed
- Registry status
- NA
- Development phase
- 248
- Enrollment target
NCT01943474 is a NA study that has completed, run by C. R. Bard. The registered enrollment target is 248 participants.
The verdict
NCT01943474, a NA study, has completed, sponsored by C. R. Bard.
- COMPLETED
- Registry status
- NA
- Development phase
- 248 participants
- Enrollment target
Study Summary
The study will test a hypothesis that the AccuCath™ System will have a higher rate of successful first attempt peripheral intravenous (IV) placement, higher completion of therapy, fewer complications, longer dwell times, and higher user satisfaction compared to conventional IV catheters.
Interventions
- DEVICE AccuCath IV Catheter Device
- DEVICE Conventional IV Catheter Device
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 248 participants |
| Start Date | 2013-04 |
| Est. Completion | 2013-10 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01943474
The ClinicalTrials.gov registry entry for NCT01943474 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 248 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is C. R. Bard, which has 75 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which AccuCath IV Catheter Device is the first listed.
NCT01943474 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01943474 about?
NCT01943474 is a clinical study titled "AccuCath Guidewire Intravenous (IV) Device Versus Conventional IV Catheter In General Nursing Use". The study will test a hypothesis that the AccuCath™ System will have a higher rate of successful first attempt peripheral intravenous (IV) placement, higher completion of therapy, fewer complications, longer dwell times, and higher user satisfaction compared to conventional IV catheters.
What is the current status of trial NCT01943474?
This trial is currently completed. It is a NA study. The enrollment target is 248 participants. The study started on 2013-04. Estimated completion is 2013-10.
What interventions are being tested in trial NCT01943474?
The interventions under investigation include: AccuCath IV Catheter Device (DEVICE), Conventional IV Catheter Device (DEVICE).
Who is sponsoring clinical trial NCT01943474?
This trial is sponsored by C. R. Bard, which has 75 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.